Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | CA9 | Q16790 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
| ▸ | CARM1 | Q86X55 | 1/20 | 0.40 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.40 |
| ▸ | PRMT8 | Q9NR22 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4312012 | 0.88 | HPGD (0.53) | HPGDDUSP3ALDH1A1KEAP1SMN1; SMN2 | |
| SCHEMBL16589287 | 0.86 | HPGD (0.47) | HPGDDUSP3ALDH1A1KEAP1SMN1; SMN2 | |
| SCHEMBL14025156 | 0.85 | PAOX (0.49) | HPGDDUSP3ALDH1A1KEAP1SMN1; SMN2 | |
| SCHEMBL25736046 | 0.84 | CARM1 (0.48) | CA12CA1CA2CA9ALDH1A1 | |
| SCHEMBL24634118 | 0.84 | KEAP1 (0.44) | CA12CA1CA2CA9TSHR | |
| SCHEMBL25903306 | 0.84 | CA12 (0.43) | CA12CA1CA2CA9TSHR | |
| SCHEMBL10409514 | 0.82 | CA12 (0.42) | CA12CA1CA2CA9TSHR | |
| SCHEMBL22456024 | 0.82 | ALDH1A1 (0.46) | CA12CA1CA2CA9TSHR | |
| SCHEMBL4569287 | 0.82 | CARM1 (0.58) | CA12CA1CA2CA9ALDH1A1 | |
| SCHEMBL13787914 | 0.82 | CARM1 (0.52) | CA12CA1CA2CA9ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 366 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11136434-B2 | Polyamines, synthesis method thereof and use thereof for the selective elimination of H2S from a gaseous effluent comprising CO2 | IFP Energies Nouvelles (FR) | 2021-10-05 | — | — | US | claimed |
| CN-108602952-B | Novel polyamines, method for their synthesis and their use for the removal of CO from a gas containing atmosphere2Selective removal of H from the gaseous effluent of2Use of S | IFP 新能源公司 | 2021-03-12 | — | — | CN | claimed |
| US-10710021-B2 | Polyamines, synthesis process thereof and use of same for the selective elimination of H2S from a gaseous effluent comprising CO2 | IFP Energies Nouvelles (FR) | 2020-07-14 | — | — | US | claimed |
| US-20200148824-A1 | NOVEL POLYAMINES, SYNTHESIS METHOD THEREOF AND USE THEREOF FOR THE SELECTIVE ELIMINATION OF H2S FROM A GASEOUS EFFLUENT COMPRISING CO2 | IFP Energies Nouvelles (FR) | 2020-05-14 | — | — | US | claimed |
| EP-3645605-A1 | NOVEL POLYAMINES, SYNTHESIS METHOD THEREOF AND USE THEREOF FOR THE SELECTIVE ELEMINATION OF H2S FROM A GASEOUS EFFLUENT COMPRISING C02 | IFP Energies nouvelles (FR) | 2020-05-06 | — | — | EP | claimed |
| EP-3397671-B1 | NOVEL POLYAMINES, SYNTHESIS PROCESS THEREOF AND USE OF SAME FOR THE SELECTIVE ELIMINATION OF H2S FROM A GASEOUS EFFLUENT COMPRISING CO2 | IFP ENERGIES NOW (FR) | 2020-02-12 | — | — | EP | claimed |
| US-20180369743-A1 | NOVEL POLYAMINES, SYNTHESIS PROCESS THEREOF AND USE OF SAME FOR THE SELECTIVE ELIMINATION OF H2S FROM A GASEOUS EFFLUENT COMPRISING CO2 | IFP Energies Nouvelles (FR) | 2018-12-27 | — | — | US | claimed |
| WO-2018224350-A1 | NOVEL POLYAMINES, SYNTHESIS METHOD THEREOF AND USE THEREOF FOR THE SELECTIVE ELIMINATION OF H2S FROM A GASEOUS EFFLUENT COMPRISING CO2 | IFP Energies Nouvelles (FR) | 2018-12-13 | — | — | WO | claimed |
| EP-3397671-A1 | NOVEL POLYAMINES, SYNTHESIS PROCESS THEREOF AND USE OF SAME FOR THE SELECTIVE ELIMINATION OF H2S FROM A GASEOUS EFFLUENT COMPRISING CO2 | IFP Energies nouvelles (FR) | 2018-11-07 | — | — | EP | claimed |
| WO-2017097716-A1 | NOVEL POLYAMINES, SYNTHESIS PROCESS THEREOF AND USE OF SAME FOR THE SELECTIVE ELIMINATION OF H2S FROM A GASEOUS EFFLUENT COMPRISING CO2 | IFP Energies Nouvelles (FR) | 2017-06-15 | — | — | WO | claimed |
| WO-2016142126-A1 | NOVEL TERTIARY POLYETHER ALKANOLAMINES, METHOD FOR SYNTHESIS THEREOF, AND USE OF SAME FOR THE SELECTIVE REMOVAL OF THE HYDROGEN SULPHIDE FROM A GAS EFFLUENT COMPRISING CARBON DIOXIDE | IFP Energies Nouvelles (FR) | 2016-09-15 | — | — | WO | claimed |
| WO-2016142125-A1 | ABSORBENT SOLUTION BASED ON AMINES COMPRISING A TERTIARY POLYETHERALKANOLAMINE, AND PROCESS FOR SELECTIVE ELIMINATION OF HYDROGEN SULPHIDE FROM A GASEOUS EFFLUENT COMPRISING CARBON DIOXIDE | IFP Energies Nouvelles (FR) | 2016-09-15 | — | — | WO | claimed |
| US-20130011314-A1 | METHOD OF REMOVING ACID COMPOUNDS FROM A GASEOUS EFFLUENT WITH AN ABSORBENT SOLUTION BASED ON I, II/III DIAMINES | IFP Energies Nouvelles (FR) | 2013-01-10 | — | — | US | claimed |
| EP-2512630-A1 | METHOD FOR REMOVING ACID COMPOUNDS FROM A GASEOUS EFFLUENT USING A DIAMINE-BASED ABSORBENT SOLUTION | IFP Energies nouvelles (FR) | 2012-10-24 | — | — | EP | claimed |
| WO-2011080405-A1 | METHOD FOR REMOVING ACID COMPOUNDS FROM A GASEOUS EFFLUENT USING A DIAMINE-BASED ABSORBENT SOLUTION | IFP Energies Nouvelles (FR) | 2011-07-07 | — | — | WO | claimed |
| US-12043620-B2 | Benzazole compounds and methods for making and using the compounds | RIGEL PHARMACEUTICALS, INC. (US) | 2024-07-23 | — | — | US | disclosed |
| US-20240239792-A1 | MODULATORS OF BCL-2 OR BCL-2/BCL-XL AND USES THEREOF | ASIA VISION LIMITED (CN) | 2024-07-18 | — | — | US | disclosed |
| US-20070105135-A1 | Charged compounds comprising a nucleic acid binding moiety and uses therefor | GENESOFT PHARMACEUTICALS, INC. (US) | 2007-05-10 | — | — | US | disclosed |
| US-20070049555-A1 | Indenoisoquinolinone analogs and methods of use thereof | INOTEK PHARMACEUTICALS CORPORATION (US) | 2007-03-01 | — | — | US | disclosed |
| US-20070032478-A1 | Kinase Inhibitors | ALLERGAN, INC. | 2007-02-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240239792-A1 | MODULATORS OF BCL-2 OR BCL-2/BCL-XL AND USES THEREOF | BCL2, BCL2L2, BCL2L1 | CA12 3373/4885CA1 2979/4885CA2 2456/4885 |
| US-12043620-B2 | Benzazole compounds and methods for making and using the compounds | IRAK3, IRAK1, IRAK2 | CA12 4877/4885CA1 4810/4885CA2 4521/4885 |
| US-20070105135-A1 | Charged compounds comprising a nucleic acid binding moiety and uses therefor | POLRMT, PCNA, SARS1 | CA12 3501/4885CA1 3304/4885CA2 1453/4885 |
| US-20070049555-A1 | Indenoisoquinolinone analogs and methods of use thereof | TNNI3, IDH2, GLS | CA12 4746/4885CA1 4454/4885CA2 4442/4885 |
| US-20070032478-A1 | Kinase Inhibitors | ABL1, LCK, ERBB2 | CA12 4024/4885CA1 3875/4885CA2 1264/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.